See more : Asana, Inc. (ASAN) Income Statement Analysis – Financial Results
Complete financial analysis of Trimurthi Limited (TRIMURTHI.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trimurthi Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Kangnam Jevisco Co., Ltd (000860.KS) Income Statement Analysis – Financial Results
- Baxter International Inc. (BTL.DE) Income Statement Analysis – Financial Results
- Purefun Group AB (publ) (PURE.ST) Income Statement Analysis – Financial Results
- Castellum AB (publ) (CAST.ST) Income Statement Analysis – Financial Results
- DFM Foods Limited (DFMFOODS.NS) Income Statement Analysis – Financial Results
Trimurthi Limited (TRIMURTHI.BO)
About Trimurthi Limited
Trimurthi Ltd. operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas. The company was founded in December 13, 1994 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.24M | 14.05M | 8.43M | 92.42M | 102.44M | 98.85M | 105.02M | 91.86M | 57.16M | 63.50M | 57.69M | 59.56M | 116.94M | 165.19M | 40.99M | 42.35M |
| Cost of Revenue | 38.36M | 13.52M | 8.08M | 85.65M | 91.67M | 90.43M | 87.51M | 77.60M | 41.13M | 45.94M | 42.40M | 45.52M | 103.71M | 154.88M | 57.21M | 307.61M |
| Gross Profit | 3.87M | 523.62K | 349.91K | 6.76M | 10.77M | 8.42M | 17.51M | 14.26M | 16.03M | 17.55M | 15.29M | 14.05M | 13.22M | 10.31M | -16.22M | -265.26M |
| Gross Profit Ratio | 9.17% | 3.73% | 4.15% | 7.32% | 10.52% | 8.52% | 16.67% | 15.52% | 28.05% | 27.64% | 26.50% | 23.58% | 11.31% | 6.24% | -39.58% | -626.28% |
| Research & Development | 0.00 | 0.00 | 218.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 800.66K | 588.96K | 500.74K | 1.48M | 1.25M | 1.40M | 1.11M | 1.16M | 994.96K | 849.09K | 710.38K | 1.18M | 774.33K | 6.09M | 4.39M | 4.71M |
| Selling & Marketing | 249.86K | 266.72K | 322.04K | 526.00K | 290.59K | 810.46K | 552.53K | 584.06K | 348.87K | 313.78K | 229.79K | 160.81K | 294.39K | 860.14K | 741.68K | 1.56M |
| SG&A | 1.02M | 855.68K | 822.78K | 2.00M | 1.54M | 2.21M | 1.66M | 1.74M | 1.34M | 1.16M | 940.16K | 1.34M | 1.07M | 6.95M | 5.13M | 6.27M |
| Other Expenses | 2.85M | -6.00K | 5.54M | 7.00K | 942.64K | 2.44M | 1.90M | 3.97K | 256.47K | 23.93K | 164.05K | 25.64K | 739.12K | 72.00K | 0.00 | 0.00 |
| Operating Expenses | 3.87M | 6.26M | 6.24M | 17.17M | 17.67M | 17.85M | 19.15M | 13.48M | 13.44M | 13.14M | 9.02M | 8.45M | 8.48M | 8.58M | 6.76M | 8.36M |
| Cost & Expenses | 42.24M | 19.79M | 14.32M | 102.82M | 109.34M | 108.28M | 106.66M | 91.08M | 54.57M | 59.08M | 51.42M | 53.97M | 112.20M | 163.46M | 63.96M | 315.97M |
| Interest Income | 2.04M | 2.73M | 2.98M | 3.34M | 4.61M | 5.78M | 81.27K | 344.60K | 570.63K | 0.00 | 0.00 | 872.00K | 5.96M | 5.14M | 4.26M | 4.30M |
| Interest Expense | 2.70K | 2.70K | 577.00K | 540.00K | 1.21M | 1.30M | 1.61M | 413.72K | 9.34K | 39.35K | 64.56K | 70.36K | 85.41K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 381.49K | 562.18K | 716.37K | 2.09M | 1.91M | 2.13M | 2.37M | 1.91M | 3.51M | 4.09M | 2.85M | 2.66M | 2.62M | 2.61M | 2.37M | 2.28M |
| EBITDA | -1.11M | -19.88K | -4.02M | -34.87M | 975.34K | 2.19M | 1.90M | 4.35M | 5.93M | 6.84M | 9.28M | 8.21M | 8.76M | 4.35M | 11.46M | 6.99M |
| EBITDA Ratio | -2.62% | -54.14% | 89.78% | -5.78% | 0.55% | 0.91% | 2.66% | 3.21% | 12.26% | 13.41% | 16.08% | 13.88% | 6.92% | 2.63% | -50.51% | -641.54% |
| Operating Income | 0.00 | -5.74M | -3.44M | -40.06M | -6.89M | -9.32M | -2.10M | 1.94M | 2.42M | 2.71M | 6.36M | 5.47M | 6.05M | 6.95M | 9.08M | 4.77M |
| Operating Income Ratio | 0.00% | -40.86% | -40.86% | -43.35% | -6.72% | -9.43% | -2.00% | 2.11% | 4.23% | 4.27% | 11.03% | 9.19% | 5.18% | 4.21% | 22.17% | 11.27% |
| Total Other Income/Expenses | 212.57K | 10.32M | -12.21M | 2.56M | -7.49M | -6.34M | -435.26K | 0.00 | 386.94K | -2.11M | 355.71K | -199.66K | -1.00 | 6.07M | 0.00 | -177.27K |
| Income Before Tax | 212.57K | -584.76K | -15.66M | -37.50M | -2.15M | -1.24M | -2.08M | 1.94M | 2.42M | 2.71M | 6.36M | 5.47M | 6.05M | 6.95M | 9.08M | 4.77M |
| Income Before Tax Ratio | 0.50% | -4.16% | -185.70% | -40.58% | -2.10% | -1.25% | -1.98% | 2.11% | 4.23% | 4.27% | 11.03% | 9.19% | 5.18% | 4.21% | 22.17% | 11.27% |
| Income Tax Expense | 108.45K | 14.54K | -54.72K | 138.00K | 441.25K | 238.45K | 1.41M | 1.60M | 1.12M | 1.29M | 2.02M | 1.70M | 1.41M | 2.23M | 2.19M | 1.49M |
| Net Income | 104.12K | -599.30K | -15.60M | -37.64M | -2.59M | -1.48M | -3.48M | -109.78K | 991.20K | 851.41K | 4.27M | 3.77M | 4.64M | 4.72M | 6.90M | 3.28M |
| Net Income Ratio | 0.25% | -4.27% | -185.05% | -40.73% | -2.53% | -1.50% | -3.32% | -0.12% | 1.73% | 1.34% | 7.40% | 6.34% | 3.97% | 2.86% | 16.83% | 7.75% |
| EPS | 0.01 | -0.07 | -1.93 | -4.65 | -0.32 | -0.18 | -0.43 | -0.01 | 0.12 | 0.11 | 0.11 | 0.55 | 0.69 | 0.70 | 1.02 | 0.05 |
| EPS Diluted | 0.01 | -0.07 | -1.93 | -4.65 | -0.32 | -0.18 | -0.43 | -0.01 | 0.12 | 0.11 | 0.11 | 0.55 | 0.69 | 0.70 | 1.02 | 0.05 |
| Weighted Avg Shares Out | 10.41M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 6.75M | 6.75M | 6.75M | 67.50M |
| Weighted Avg Shares Out (Dil) | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 8.10M | 6.75M | 6.75M | 6.75M | 67.50M |
Source: https://incomestatements.info
Category: Stock Reports